Initial Results From Oxford COVID Vaccine Trial Appear Hopeful
The Oxford University-AstraZeneca vaccine trial is one of three -- with CanSino Biologics and Pfizer-BioNTech leading the other two -- that are reporting only minor side effects, coupled with strong immune response.